Gao et al. proposed that estrogen receptor alpha (ERα) can inhibit GSDMD-mediated pyroptosis to improve MAFLD (Gao et al., 2021), suggesting that ERα may be a potential target for NAFLD treatment. This evidence concerns the gene ESR1 and metabolic dysfunction-associated steatotic liver disease.